| Literature DB >> 2498571 |
R Paschke1, U Schwedes, H Kühnle, J Peter, R Schmeidl, K H Usadel.
Abstract
Many compounds which directly or indirectly inhibit gluconeogenesis have been described. Some of them showed hypoglycemic action in animal experiments. 2-(3-Methylcinnamylhydrazono)-Propionat (MCHP) a derivative of hydrazine demonstrated marked hypoglycemic action in animal experiments. Nontheless the administration of MCHP to type II diabetic patients showed no hypoglycemic action. Clinical or biochemical sideeffects could not be observed.Entities:
Mesh:
Substances:
Year: 1989 PMID: 2498571 DOI: 10.1007/bf01725138
Source DB: PubMed Journal: Klin Wochenschr ISSN: 0023-2173